Antibody Responses to Vaccinia Membrane Proteins after Smallpox Vaccination
Open Access
- 15 July 2007
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (2), 220-229
- https://doi.org/10.1086/518793
Abstract
Background. Vaccinia virus (VV) membrane proteins are candidates for orthopoxvirus subunit vaccines and potential targets for therapeutic antibodies.Keywords
This publication has 45 references indexed in Scilit:
- Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccinationNature Medicine, 2006
- Human T-Cell Responses to Vaccinia Virus Envelope ProteinsJournal of Virology, 2006
- Myopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military PersonnelJAMA, 2003
- Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primatesVirology, 2003
- The formation and function of extracellular enveloped vaccinia virusJournal of General Virology, 2002
- Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditionsJournal of General Virology, 2002
- Clinical Responses to Undiluted and Diluted Smallpox VaccineNew England Journal of Medicine, 2002
- Dose-Related Effects of Smallpox VaccineNew England Journal of Medicine, 2002
- Antibody Neutralization of the Extracellular Enveloped Form of Vaccinia VirusVirology, 2001
- The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particlesMicrobiology, 2000